<DOC>
	<DOCNO>NCT02245230</DOCNO>
	<brief_summary>The purpose study well understand cardiovascular effect vasodilatory peptide Angiotensin ( 1-7 ) human hypertension . In study , investigator test hypothesis systemic Angiotensin ( 1-7 ) infusion produce negligible effect intact baroreceptor , cardiovascular effect peptide unmask follow elimination baroreflex buffering .</brief_summary>
	<brief_title>Cardiovascular Effects Angiotensin ( 1-7 ) Essential Hypertension</brief_title>
	<detailed_description>Pharmacologic approach increase level action vasodilatory peptide Angiotensin ( 1-7 ) currently development treatment hypertension base finding animal study . There limited contradictory clinical study , however , unclear peptide even contribute blood pressure regulation human . The purpose study learn cardiovascular effect Angiotensin ( 1-7 ) essential hypertension , examine interaction peptide autonomic nervous system blood pressure regulation . The investigator propose difficulty show Angiotensin ( 1-7 ) cardiovascular effect previous clinical study relate buffer capacity baroreceptor reflex prevent change blood pressure . In study , investigator test hypothesis Angiotensin ( 1-7 ) produce negligible effect intact baroreceptor , cardiovascular effect peptide unmask follow elimination baroreflex buffer . To test hypothesis , investigator examine effect acute intravenous Angiotensin ( 1-7 ) infusion blood pressure subject essential hypertension intact condition follow acute autonomic withdrawal ganglionic blocker trimethaphan . The primary outcome decrease systolic blood pressure produce Angiotensin ( 1-7 ) infusion , comparison make intact blocked study day . As secondary objective , investigator examine change systemic hemodynamics circulate hormone response Angiotensin ( 1-7 ) infusion , determine potential mechanism underlie change blood pressure .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Trimethaphan</mesh_term>
	<mesh_term>Angiotensin I ( 1-7 )</mesh_term>
	<mesh_term>Trimethaphan camsylate</mesh_term>
	<criteria>Males female race 18 60 year age Hypertension define two properly measure seat blood pressure reading &gt; 130/85 mmHg . This allow u include subject `` prehypertension . '' Able willing provide inform consent Pregnancy breast feed Current smoker history heavy smoking ( &gt; 2 packs/day ) History alcohol drug abuse Previous allergic reaction study medication Evidence type I type II diabetes ( i.e . fast glucose &gt; 126 mg/dl , use antidiabetic medication ) Cardiovascular disease hypertension myocardial infarction within 6 month prior enrollment , presence angina pectoris , significant arrhythmia , congestive heart failure ( LV hypertrophy acceptable ) , deep vein thrombosis , pulmonary embolism , second third degree heart block , mitral valve stenosis , aortic stenosis , hypertrophic cardiomyopathy History serious cerebrovascular disease cerebral hemorrhage , stroke , transient ischemic attack History presence immunological hematological disorder Impaired hepatic function [ aspartate amino transaminase ( AST ) and/or alanine amino transaminase ( ALT ) &gt; 2.0 x upper limit normal range ] Impaired renal function ( serum creatinine &gt; 1.5 mg/dl ) Anemia ( hemoglobin &lt; 13.5 g/dl male &lt; 12.5 g/dl female ) Treatment phosphodiesterase 5 inhibitor Treatment anticoagulant Treatment chronic systemic glucocorticoid therapy ( 7 consecutive day 1 month ) Treatment investigational drug 1 month precede study Inability give , withdraw , informed consent Other factor investigator 's opinion would prevent subject complete protocol ( i.e . clinically significant abnormality clinical , mental examination laboratory test inability comply protocol )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Autonomic Nervous System</keyword>
	<keyword>Renin-Angiotensin System</keyword>
	<keyword>Angiotensin ( 1-7 )</keyword>
	<keyword>Ganglionic Blockers</keyword>
	<keyword>Trimethaphan</keyword>
	<keyword>Blood Pressure</keyword>
	<keyword>Hemodynamics</keyword>
</DOC>